>>> US Gapping up

Gapping up

Gapping up
In reaction to strong earnings/guidance:

  • RHT +6.2%, MKC +3.8%, CC +1.1%, WBAI +1%

M&A news:

  • GGP +2.3% (BPY to acquire outstanding GGP common stock)

Other news:

  • FENC +12.4% (receives breakthrough therapy designation by FDA for Pedmark)
  • ITUS +8.5% (announces results of blinded prostate cancer study)
  • ECR +6.2% (provides updated projections regarding Marcellus Condensate type curve; initiates strategic review)
  • EKSO +2.4% (after closing near highs - up 35% on the day)
  • QTNT +2.2% (reports concordance data for the MosaiQ blood grouping microarray generated in recent V&V head-to-head studies; CEO retires)
  • ESPR +2.2% (positive top-line results from Phase 2 clinical study in patients with hypercholesterolemia)
  • ATRS +1.4% (receives official minutes from Type A meeting with FDA regarding XYOSTED NDA)
  • TVPT +1.2% (continued strength after Elliott disclosed stake)
  • BLDP +0.8% (unit receives $1.9 mln follow-on order from US Army)

Analyst comments:

  • ADMS +4.4% (initiated with a Buy at BofA/Merrill)
  • BBT +2.1% (upgraded to Outperform from Market Perform at Wells Fargo)
  • LRCX +1.8% (initiated with a Buy at Mizuho)